Explore

Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy

Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy

Evofem Biosciences Reports Q1 2026 Financial Results Highlighting Revenue Diversification Strategy
Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion

Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion

Evofem Biosciences Reports Q1 2026 Financial Results Amid Strategic Expansion
Trendline Trendline
Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion

Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion

Evofem Biosciences Reports Q1 2026 Financial Results with Strategic Global Expansion
Trendline Trendline
Iridex Reports Q1 2026 Financial Results with Net Loss of $0.5 Million

Iridex Reports Q1 2026 Financial Results with Net Loss of $0.5 Million

Iridex Reports Q1 2026 Financial Results with Net Loss of $0.5 Million
Trendline Trendline
Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate

Enveric Biosciences Reports Q1 2026 Financial Results and Advances Lead Drug Candidate
Trendline Trendline
Sohu.com Reports Q1 2026 Financial Results with Revenue Growth and Net Loss

Sohu.com Reports Q1 2026 Financial Results with Revenue Growth and Net Loss

Sohu.com Reports Q1 2026 Financial Results with Revenue Growth and Net Loss
Trendline Trendline
Eastern Platinum Reports Reduced Net Loss and Costs in Q1 2026

Eastern Platinum Reports Reduced Net Loss and Costs in Q1 2026

Eastern Platinum Reports Reduced Net Loss and Costs in Q1 2026
Trendline Trendline
Sohu.com Reports First Quarter 2026 Financial Results with Revenue Growth

Sohu.com Reports First Quarter 2026 Financial Results with Revenue Growth

Sohu.com Reports First Quarter 2026 Financial Results with Revenue Growth
Trendline Trendline
Thor Explorations Reports Significant Increase in Q1 2026 Net Income Amidst Gold Production Challenges

Thor Explorations Reports Significant Increase in Q1 2026 Net Income Amidst Gold Production Challenges

Thor Explorations Reports Significant Increase in Q1 2026 Net Income Amidst Gold Production Challenges
Trendline Trendline
Citius Oncology Secures $36.5 Million Financing Amid Strong LYMPHIR Launch

Citius Oncology Secures $36.5 Million Financing Amid Strong LYMPHIR Launch

Citius Oncology Secures $36.5 Million Financing Amid Strong LYMPHIR Launch
Trendline Trendline
Citius Oncology Reports Q2 2026 Financial Results Highlighting LYMPHIR Launch Success

Citius Oncology Reports Q2 2026 Financial Results Highlighting LYMPHIR Launch Success

Citius Oncology Reports Q2 2026 Financial Results Highlighting LYMPHIR Launch Success
Trendline Trendline
Eastern Platinum Reports Improved Financial Performance in Q1 2026

Eastern Platinum Reports Improved Financial Performance in Q1 2026

Eastern Platinum Reports Improved Financial Performance in Q1 2026